Section Arrow
TSHA.NASDAQ
- Taysha Gene Therapies
Quotes are at least 15-min delayed:2025/11/19 03:46 EST
Pre Market
Last
 --
-- (--)
Bid
--
Ask
--
High -- 
Low -- 
Volume -- 
Regular Hours
Last
 4.15
+0.03 (+0.73%)
Day High 
4.335 
Prev. Close
4.12 
1-M High
5.33 
Volume 
2.73M 
Bid
--
Ask
--
Day Low
4.05 
Open
4.12 
1-M Low
3.6929 
Market Cap 
1.13B 
Currency USD 
P/E 2.44 
%Yield -- 
10-SMA 4.08 
20-SMA 4.49 
50-SMA 4.12 
52-W High 5.5082 
52-W Low 1.05 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.33/-0.41
Enterprise Value
1.19B
Balance Sheet
Book Value Per Share
0.80
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
8.33M
Operating Revenue Per Share
0.04
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
CANFCan-Fite BioPharma Ltd0.3801+0.0181+5.00%-- 
Pre Market -- -- --
ASBPAspire Biopharma Holdings Inc.0.1057+0.0144+15.77%-- 
Pre Market -- -- --
OLMAOlema Pharmaceuticals20.14+11.62+136.38%-- 
Pre Market -- -- --
CMNDClearmind Medicine0.2164-0.0605-21.85%0.16PE
Pre Market -- -- --
APLTApplied Therapeutics0.2984+0.0142+5.00%-- 
Pre Market -- -- --
Quotes are at least 15-min delayed:2025/11/19 03:46 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.